Reinhold Horlacher is the Founder, CEO, and CSO of trenzyme GmbH, a contract research organization he established in 2000. With a Ph. D. in molecular biology from the University of Konstanz and over 30 years of experience, he leads his team in delivering tailored solutions in protein production, cell line development, and stem cell services.
Reinhold has a deep-rooted passion for scientific advancement, having worked with proteins for roughly four decades. He often reflects on the evolution of research methodologies and is dedicated to translating complex science into real-world applications. His hands-on approach is evident as he actively engages in solving nuanced laboratory challenges with his team.
He is a co-inventor on a patent for a post-exposure nasal vaccine designed to protect against respiratory viruses like SARS-CoV-2 and influenza.
Read the full overview →They prefer to analyze logically and value objective facts over emotions. They like to take decisions independently and do not seek others' support often. They are quite likely to negotiate on pricing or other key terms.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.